Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

eXoZymes, Inc. (EXOZ)

13.53
+1.74
+(14.76%)
At close: 4:00:01 PM EDT
13.53
0.00
(0.00%)
After hours: 4:05:07 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
5,932.11
5,932.11
1,796.22
1,332.67
1,292.85
Operating Income
-5,932.11
-5,932.11
-1,796.22
-1,332.67
-1,292.85
Net Non Operating Interest Income Expense
77.61
77.61
0.10
0.10
--
Other Income Expense
-6.84
-6.84
-200
--
83.74
Pretax Income
-5,861.34
-5,861.34
-1,996.12
-1,332.57
-1,209.11
Tax Provision
--
--
42.27
63.56
--
Net Income Common Stockholders
-5,861.34
-5,861.34
-2,038.39
-1,396.13
-1,209.11
Diluted NI Available to Com Stockholders
-5,861.34
-5,861.34
-2,038.39
-1,396.13
-1,209.11
Basic EPS
-0.89
--
-0.25
-0.17
-0.15
Diluted EPS
-0.89
--
-0.25
-0.17
-0.15
Basic Average Shares
6,563.26
--
8,127.35
8,127.35
8,127.35
Diluted Average Shares
6,563.26
--
8,127.35
8,127.35
8,127.35
Total Operating Income as Reported
-5,932.11
-5,932.11
-1,796.22
-1,332.67
-1,292.85
Total Expenses
5,932.11
5,932.11
1,796.22
1,332.67
1,292.85
Net Income from Continuing & Discontinued Operation
-5,861.34
-5,861.34
-2,038.39
-1,396.13
-1,209.11
Normalized Income
-5,861.33
-5,861.33
-1,880.39
-1,396.13
-1,292.85
Interest Income
--
--
0.10
0.10
--
Net Interest Income
77.61
77.61
0.10
0.10
--
EBIT
-5,932.11
-5,932.11
-1,796.22
-1,332.67
-1,292.85
EBITDA
-5,664.72
-5,664.72
-1,599.29
-1,184.92
-1,233.44
Reconciled Depreciation
267.38
267.38
196.94
147.75
59.41
Net Income from Continuing Operation Net Minority Interest
-5,861.34
-5,861.34
-2,038.39
-1,396.13
-1,209.11
Total Unusual Items Excluding Goodwill
-0.01
-0.01
-200
--
83.74
Total Unusual Items
-0.01
-0.01
-200
--
83.74
Normalized EBITDA
-5,664.72
-5,664.72
-1,399.29
-1,184.92
-1,317.18
Tax Rate for Calcs
--
--
0
0
--
Tax Effect of Unusual Items
--
--
-42
--
--
12/31/2021 - 11/13/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CUE Cue Biopharma, Inc.
0.8363
+6.85%
 
1OT.F Ovid Therapeutics Inc.
0.1960
-5.77%
 
RXK3.F SELLAS Life Sciences Group, Inc.
1.1760
+8.89%
 
LTI0.F Aptose Biosciences Inc. R
2.0200
+1.00%
 
1VT.MU Viking Therapeutics Inc
22.37
+7.65%
 
GOVXW GeoVax Labs, Inc.
0.0300
-0.33%
 
APTOF Aptose Biosciences Inc.
2.3100
-6.48%
 
CLVLY Clinuvel Pharmaceuticals Limited
7.10
0.00%
 
BINV.ST BioInvent International AB (publ)
29.10
+3.19%
 
WHWK Whitehawk Therapeutics, Inc.
1.5400
0.00%